We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Scanning Method Combines Two MRI Techniques to Detect Deadly Heart Condition Before Symptoms Appear

By MedImaging International staff writers
Posted on 20 Jul 2023
Print article
Image: New scanning methods can detect deadly hypertrophic cardiomyopathy ahead of symptoms (Photo courtesy of UCL)
Image: New scanning methods can detect deadly hypertrophic cardiomyopathy ahead of symptoms (Photo courtesy of UCL)

Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by thicker than normal heart muscle walls, affecting the heart's ability to pump blood efficiently. HCM is a primary cause of heart failure and sudden cardiac death. A new study has revealed that a combination of two types of heart scan techniques could enable medical professionals to detect HCM earlier than current conventional tests allow. This early detection of HCM could also support trials exploring gene therapies and medications aimed at preventing the disease's development in high-risk individuals.

In collaborative research involving investigators from University College London (UCL, London, UK), the team analyzed the hearts of three groups: healthy individuals, patients already diagnosed with HCM, and people with an HCM-inducing genetic mutation but no observable signs of the disease (no heart muscle thickening). The team employed two advanced heart scanning techniques: cardiac diffusion tensor imaging (cDTI), a type of MRI scan that reveals how individual heart muscle cells are organized and packed together (the heart's microstructure), and cardiac MRI perfusion (perfusion CMR), which identifies problems with small blood vessels supplying the heart muscle (microvascular disease).

The scans revealed that individuals with overt HCM symptoms exhibit severely disorganized heart muscle cells and a high incidence and severity of microvascular disease compared to healthy participants. Importantly, the scans were also capable of detecting abnormal microstructure (muscle cell disorganization) and microvascular disease in those carrying the problematic gene yet without any symptoms or muscle thickening. The researchers found that 28% of these individuals had blood supply defects compared to healthy volunteers. This enabled doctors to more accurately identify early HCM signs developing in patients' hearts.

Mavacamten - the first medication to slow HCM progression - recently received approval in Europe, allowing doctors to mitigate the disease's severity once symptoms and muscle thickening become apparent. In addition, genetic therapies are being developed that could potentially prevent symptoms altogether by intercepting HCM at an early stage. Perfusion CMR is already employed in some clinics to distinguish HCM patients from other causes of muscle thickening. The researchers believe that these groundbreaking therapies, combined with cDTI and perfusion CMR scans, offer doctors the best opportunity yet to treat high-risk HCM individuals early enough to prevent the disease's development.

“The ability to detect early signs of HCM could be crucial in trials testing treatments aimed at preventing early disease from progressing or correcting genetic mutations. The scans could also enable treatment to start earlier than we previously thought possible,” said Dr. George Joy from the UCL Institute of Cardiovascular Science who led the research. “We now want to see if we can use the scans to identify which patients without symptoms or heart muscle thickening are most at risk of developing severe HCM and its life-changing complications. The information provided from scans could therefore help doctors make better decisions on how best to care for each patient.”

Related Links:
UCL 

Gold Supplier
Conductive Gel
Tensive
New
Gold Supplier
IMRT Thorax Phantom
CIRS Model 002LFC
Gold Supplier
128 Slice CT Scanner
Supria 128
New
Advanced Radiotherapy System
uRT-linac 306

Print article
Sun Nuclear -    Mirion

Channels

Radiography

view channel
Image: The AI model improves tumor removal accuracy during breast cancer surgery (Photo courtesy of UNC School of Medicine)

AI Model Analyzes Tumors Removed Surgically in Real-Time

During breast cancer surgery, the surgeon removes the tumor, also known as a specimen, along with a bit of the adjacent healthy tissue to ensure all cancerous cells are excised. This specimen is then X-rayed... Read more

Ultrasound

view channel
Image: FloPatch is a revolutionary tool that facilitates real-time precision in IV fluid management in sepsis (Photo courtesy of Flosonics)

Wireless, Wearable Doppler Ultrasound Revolutionizes Precision Fluid Management in Sepsis Care

When a patient comes to the hospital with sepsis, administering intravenous (IV) fluids is usually the first course of action. However, too much IV fluid can do more harm than good, causing additional... Read more

Nuclear Medicine

view channel
Image: An AI model can evaluate brain tumors on PET (Photo courtesy of Freepik)

AI Model for PET Imaging Determines Patient Response to Brain Tumor Treatments

The assessment of changes in metabolic tumor volume (MTV) through PET scans using specific radiotracers like F-18 fluoroethyl tyrosine (FET) plays a vital role in evaluating the treatment response in patients... Read more

General/Advanced Imaging

view channel
Image: Annalise Enterprise CTB acts like a ‘second pair of eyes’ for radiologists (Photo courtesy of Annalise.ai)

Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

Non-contrast computed tomography of the brain (NCCTB) is a commonly employed method for identifying intracranial pathology. Despite its frequent use, the complex scan outcomes are prone to being misunderstood.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.